"10.1371_journal.pone.0032445","plos one","2012-03-29T00:00:00Z","Thomas A Rasmussen; Danny Jensen; Martin Tolstrup; Ulla S Nielsen; Erland J Erlandsen; Henrik Birn; Lars Østergaard; Bente L Langdahl; Alex L Laursen","Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Department of Nephrology, Aarhus University Hospital and Institute of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Clinical Biochemistry, Viborg Regional Hospital, Viborg, Denmark; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark","Conceived and designed the experiments: TAR MT LØ ALL USN. Performed the experiments: DJ HB EJE BLL. Analyzed the data: TAR ALL LØ HB. Contributed reagents/materials/analysis tools: EJE HB DJ BLL. Wrote the paper: TAR ALL HB BLL.","The study was supported by a grant of US$ 9,100 from GlaxoSmithKline (www.gsk.com). Lars Østergaard has received consultancy and speakers fee from: Abbott, MSD, Pfizer, Bristol-Meyer Squibb, GlaxoSmithKline, ViiV Healthcare, Gilead, and Tibotec. Alex L Laursen has served on the advisory board for GlaxoSmithKline, Gilead, and Janssen. Lamivudine/zidovudine and abacavir/lamivudine are manufactured by GSK; tenofovir/emtricitabine is manufactured by Gilead. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Thomas A Rasmussen","TAR",9,TRUE,5,4,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
